A large family in which hypoparathyroidism was observed to segregate as an autosomal dominant trait in three generations was identilied. Mutation in the FTH gene was excluded by linkage and single-stranded conformational analysis. The hypocalcemic phenotype in this family was mapped by linkage analysis using short, tandem-repeat polymorphisms to the region of chromosome 3q13. A maximum lod score of 2.71 at O = 0.0 was observed with marker D3S1303. Positive lod scores were observed at O = 0.0 with markers flanking D3S1303. Multipoint linkage analysis gave a lod score of 2.71 for the region flanking D3S1303. Simulation using the computer program SLINK showed that a lod score of 2.71 at O = 0.0 was the maximum lod score possible given the pedigree structure. The simulation also showed that given the structure of the pedigree the probability of observing a lod score of 2.71 at O = 0.0 by chance was 1 in 1000. The data presented above provide important preliminary evidence supporting linkage to chromosome 3q13. This region contains a Ca2+-sensing receptor gene that is proposed as a key signal transduction element for changes in extracellular Ca2+ concentrations in mechanisms of regulation of PTH secretion from parathyroid cells. The mutation in this family may activate the ca2+-sensing receptor suppressing FTH secretion and lowering the "set point" for serum calcium levels. (Pediafr Res 36: [414][415][416][417] 1994) Idiopathic hypoparathyroidism is an unusual endocrine deficiency characterized by decreased levels of PTH without an obvious etiology such as surgical trauma. The clinical presentation is variable, with symptoms ranging from mild parasthesias to tetany and convulsions. Hypocalcemia and hyperphosphatemia are commonly seen and vary in severity. Familial clustering of hypoparathyroidism has been described with transmission patterns consistent with autosomal dominant, autosomal recessive, and X-linked inheritance. The mechanism of at least some of the recessively inherited forms has been characterized as mutations in the sequence of the PTH gene (1-3). On the other hand, hypoparathyroidism with an autosomal dominant pattern of transmission has been reported to be unlinked to the PTH locus (4, 5) and is unlikely to represent a simple mutation within the PTH gene sequence. We had the opportunity to study three generations of a family with inherited hypoparathyroidism, demonstrating an autosomal dominant transmission pattern. In this family, hypocalcemia was rarely clinically manifested, hypoparathyroidism was unlinked to the PTH locus, and no abnormality in the PTH coding sequence was detected by single-stranded DNA conformational analysis (data not shown). In light of these results, we reasoned that autosomal dominant hypoparathyroidism must be explained by a mutation other than in the PTH gene. Using highly informative microsatellite markers, we have preliminary evidence that the locus responsible for the hypoparathyroid phenotype in this family maps to chromosome 3q13.
the maximum lod score possible given the pedigree structure. The simulation also showed that given the structure of the pedigree the probability of observing a lod score of 2.71 at O = 0.0 by chance was 1 in 1000. The data presented above provide important preliminary evidence supporting linkage to chromosome 3q13. This region contains a Ca2+-sensing receptor gene that is proposed as a key signal transduction element for changes in extracellular Ca2+ concentrations in mechanisms of regulation of PTH secretion from parathyroid cells. The mutation in this family may activate the ca2+-sensing receptor suppressing FTH secretion and lowering the "set point" for serum calcium levels. (Pediafr Res 36: [414] [415] [416] [417] 1994) Idiopathic hypoparathyroidism is an unusual endocrine deficiency characterized by decreased levels of PTH without an obvious etiology such as surgical trauma. The clinical presentation is variable, with symptoms ranging from mild parasthesias to tetany and convulsions. Hypocalcemia and hyperphosphatemia are commonly seen and vary in severity. Familial clustering of hypoparathyroidism has been described with transmission patterns consistent with autosomal dominant, autosomal recessive, and X-linked inheritance. The mechanism of at least some of the recessively inherited forms has been characterized as mutations in the sequence of the PTH gene (1) (2) (3) . On the other hand, hypoparathyroidism with an autosomal dominant pattern of transmission has been reported to be unlinked to the PTH locus (4, 5) and is unlikely to represent a simple mutation within the PTH gene sequence. We had the opportunity to study three generations of a family with inherited hypoparathyroidism, demonstrating an autosomal dominant transmission pattern. In this family, hypocalcemia was rarely clinically manifested, hypoparathyroidism was unlinked to the PTH locus, and no abnormality in the PTH coding sequence was detected by single-stranded DNA conformational analysis (data not shown). In light of these results, we reasoned that autosomal dominant hypoparathyroidism must be explained by a mutation other than in the PTH gene. Using highly informative microsatellite markers, we have preliminary evidence that the locus responsible for the hypoparathyroid phenotype in this family maps to chromosome 3q13.
METHODS

Genotyping.
Genomic DNA was isolated from peripheral blood. Amplification primers were synthesized using sequence information from the Genome Database and end labeled by standard procedures. Genomic DNA was polymerase chain reaction amplified with 0.144 FM labeled primers and 0.8 FM unlabeled primers by standard protocol. Amplification was conducted for 30 cycles at 94°C for 1 min, 52°C for 1 min, and 72°C for 1 min, with a final one-cycle extension at 72°C for 5 min. Amplified products were electrophoresed on standard denaturing 7% acrylamide/35% formamide DNA sequencing gels.
Linkage analyses. We tested for linkage in this family between hypoparathyroidism and the following 11 microsatellite loci on chromosome 3q: D3S1302, D3S1278, D3S1310, D3S1303, D3S1267, D3S1269, D3S1273, D3S1290, D3S1292 (6), RHO, and ACPP (7). The LINK-AGE programs MLINK, LODSCORE, and LINKMAP (8) were used for two-point and multipoint linkage analyses. The disease was assumed to be autosomal dominant with complete penetrance and a disease gene frequency of 0.001. For the two-point analyses, allele frequencies reported in the Human Genome Data Base (9) were used where possible; otherwise, frequencies were estimated from unrelated founders. Because no recombinants were detected between D3S1290 and D3S1292 in our family and in eight CEPH families (6), D3S1290 was used to represent this locus, inasmuch as it was more informative in this family. Markers D3S1310 and D3S1278 could not be ordered unequivocally in CEPH families. We used D3S1278 in multipoint analysis because it was the most informative in our family.
Marker order for the multipoint linkage analysis was determined by using CRI-MAP (10) to refine the map of this region as reported in Matise et al. (11) . The map order and intermarker recombination fractions were D3S 1302-0.04-D3S 1278-0.07-D3S1303-0.03-D3S1267-0.01-D3S1269-0.07-D3S1273-0.02-D3S129~0.001 -RHO-0.06-ACPP. Braverman's recoding algorithm (12) was used to reduce the number of alleles for some markers. We repeated the two-point linkage analysis with the recoded markers to validate the recoded alleles and obtained lod scores equal to or slightly lower than those estimated with the original alleles. We performed several overlapping multipoint analyses, computing the lod score at each map position within each interval. Lod scores were plotted for the innermost map interval of each multipoint analysis, with the exception of the terminal map intervals.
We used the SLINK and MSIM simulation and analysis program (13, 14) to estimate the likelihood of obtaining significant two-point lod scores in this pedigree. We generated 2000 replicates of this pedigree using the observed phenotypes and simulating a marker with the same allele frequencies as D3S1303. The allele frequencies of D3S1303 were used because this marker had the highest two-point lod score. Simulations were performed under both a completely linked model (O = 0.0) and a completely unlinked model (O = 0.5).
RESULTS
Family.
A 2-mo-old boy was referred to the endocrine clinic of the Children's Hospital of Pittsburgh with a history of hypocalcemia at 1 d of age and a strong maternal family history of hypocalcemia. Because of the family history, the referring physician had determined the infant's serum calcium level shortly after birth and noted a reduced level of 1.75 mM. The infant showed no signs of neuromuscular irritability, tetany, or seizures, but was started on oral calcium supplements. Repeat c a 2 + determinations continued to be slightly low at 2.07-2.12 mM. On presentation to the endocrine clinic, a remarkable family history was elicited. The child's mother had a history of hypocalcemia since early childhood, with hypocalcemic seizures at age 3-4 y and again at 13-14 y during intercurrent illness. She was currently not on any medications but remembered receiving medications to treat hypocalcemia in the past. The pedigree (Fig. 1) based on a family history of hypocalcemia demonstrates an autosomal dominant pattern of inheritance. On physical examination, the proband appeared to be a healthy infant without dysmorphic features. Height was 56 cm (25th percentile). Weight was 5.64 kg (75th percentile). Head circumference was 38 cm (25th percentile). The remainder of the examination was unremarkable, with the exception of an aortic ejection murmur that was later evaluated and felt to be caused by a bicuspid aortic valve. In view of the family history, physical examination, and laboratory results, calcium supplementation was discontinued without exacerbation of symptoms or further decrease in serum c a 2 + concentrations.
The results of the biochemical analysis from family members demonstrated a separation in serum calcium Linkage analysis. Recent evidence has supported the existence of a ca2+-sensing receptor as an element of the mechanisms regulating PTH secretion from parathyroid cells (15) . The human ca2+-sensing receptor gene has recently been mapped to chromosome 3. We tested our family for linkage between hypoparathyroidism and a series of short, tandem-repeat polymorphisms spanning the approximate location of the ca2+-sensing receptor locus. The results of the linkage analysis are presented in Table 1 . A maximum lod score of 2.71 (odds favoring linkage > 500:l) at O = 0.0 for marker D3S1303 was observed. Positive lod scores were observed at O = 0.0 with markers D3S1302, D3S1278, D3S 1267, D3S 1269, and RHO, which flank D3S1303 and the locus for hypoparathyroidism. The observed pattern of lod scores is consistent with the known order of these markers on chromosome 3q13.
Multipoint lod score analysis using nine markers gave a lod score of 2.71 for the region flanking the marker D3S1303. Multipoint linkage analysis using all informative markers gives a l-lod confidence interval for assignment of a gene for autosomal dominant hypoparathyroidism t o a 47-centimorgan region of human chromosome 3q13 flanking the marker D3S1303. To evaluate the linkage results, we used SLINK (13, 14) (see Methods) to simulate the segregation of marker alleles in this pedigree under two assumptions: first, that the marker locus was linked to the phenotype with no recombination; and second, that the marker was unlinked to the 
DISCUSSION
Linkage to multiple microsatellite markers supports the preliminary assignment of a gene responsible for hypoparathyroidism to chromosome 3q13. In this family, the lod score for linkage was 2.71, and multipoint analysis did not increase the lod score because marker D3S1303 was completely informative. Using the general simulation program for linkage analysis SLINK to simulate segregation of an unlinked marker, the likelihood of the observed lod score seen in our family appearing by chance was 1 in 1000. Similarly, assuming linkage, the predicted maximum lod score for this family was 2.71, as observed for marker D3S1303 and haplotypes for markers D3S1302, D3S1278, D3S1310, D3S1303, D3S1267, and D3S1269. The cosegregation of the hypoparathyroidism phenotype with six highly informative microsatellite markers, the observation of the maximum possible lod score in this family for the marker D3S1303, and the low probability of observing a lod score of 2.71 in this family by chance alone (p 5 0.001) all support the assignment of a gene causing hypoparathyroidism to human chromosome 3q13.
Recent work has expanded our knowledge of the regulation of extracellular c a 2 + and PTH. Brown (15) has reviewed the evidence addressing the mechanisms that control PTH secretion from parathyroid cells. Acute regulation of PTH secretion appears to be modulated by a Ca2+-sensing receptor coupled via a G protein-mediated mechanism of activation of phospholipase C, affecting levels of inositol triphosphate. Such a receptor has been cloned and characterized from bovine parathyroid cells and expressed in Xenopus oocytes (16) . The human receptor has been mapped to chromosome 3q by Pollak et al. (17) . The ca2+-sensing receptor gene has the motif of the seven membrane-spanning domain G protein-coupled receptors. Mutations in the human ca2+-sensing receptor gene have been linked to neonatal severe hyperparathyroidism and familial hypocalciuric hypercalcemia (17, 18) . These mutations result in a loss of function of the ca2+-sensing receptor determined in a Xenopus expression assay.
The ca2+-sensing receptor gene is a likely candidate for the phenotype seen in our family. The hypocalcemia is mild, and none of the family members have required hormonal or calcium supplementation beyond childhood. This would be consistent with the single dose of the gene inferred from the linkage analysis. Depression in PTH secretion would predict a gain of function mutation, forcing the receptor to the "on" state. The mild hypocalcemic phenotype segregates in this family as an autosomal dominant trait. However, in a manner similar to the observations of loss of function mutations seen in neonatal severe hyperparathyroidism (17, 18) , a double dose of gain of function mutation might be expected to cause severe hypocalcemia requiring vitamin D and ca2+ supplementation. Previous reports of inherited hypoparathyroidism have been explained by mutations in the PTH gene or were ascribed to "anatomic" malformations of the parathyroid glands. We believe at least a subset of familial dominant hypoparathyroidism may be explained by mutations in the PCARl gene.
Khosla et al. (19) and Marx et al. (20) have suggested that familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism represent "set-point7' abnormalities in the maintenance of extracellular c a 2 + concentration. The potential for heterogeneity in "set-point" for serum c a 2 + concentration raises the possibility that mildly affected probands may have other unsuspected hypocalcemic relatives. This would be similar to the initial reports in familial hypocalciuric hypercalcemia of individuals in the pedigrees with unsuspected hypercalcemia. Families of individuals diagnosed with hypoparathyroidism and absent parathyroid antibodies should be screened for mild hypocalcemia to avoid unnecessary treatment with calcium and vitamin D supplementation and identify the potential risk for hypocalcemic seizures during childhood illnesses.
